Effect of the milk-whey relation over physicochemical and rheological properties on a fermented milky drink

(Eng) The effect of the milk-whey relation over the physicochemical properties (pH, total acidity, soluble solids and syneresis) and rheology (deformation rate, apparent viscosity, flow behavior index and consistency index) of a fermented dairy drink was studied. A completely randomized experimental design of two factors: percentage of whey (0, 5, 10 and 15% w/w) and type of milk (whole and skim) was used. The significance was determined using an analysis of variance (ANOVA). All properties analyzed except pH had statistically significant differences (P<0.05). The use of whole milk in comparison to skim milk generated an increase in soluble solids and viscosity of the beverage but caused a decrease in acidity and syneresis. The growth in whey concentration increased syneresis and apparent viscosity but decreased soluble solids and consistency index. The changes in properties are related to the contribution of fat from milk and the contribution of calcium and phosphate from whey, affecting both the interaction between the casein micelles and the water retention capacity, which changes the composition and fluidity of the beverage.(Spa) Se estudió el efecto de la relación leche-lactosuero sobre las propiedades fisicoquímicas (pH, acidez total, sólidos solubles y sinéresis) y reológicas (velocidad de deformación, viscosidad aparente, índice de comportamiento al flujo e índice de consistencia) de una bebida láctea fermentada. Se utilizó un diseño experimental completamente al azar de dos factores: porcentaje de lactosuero (0, 5, 10 y 15% p/p) y tipo de leche (entera y descremada). La significancia se determinó mediante un análisis de varianza (ANOVA). Todas las propiedades analizadas excepto el pH presentaron diferencias estadísticamente significativas (P<0,05). El uso de la leche entera en comparación con la leche descremada generó un incremento en los sólidos solubles y en la viscosidad de la bebida, pero causó una disminución en la acidez y la sinéresis. El incremento en la concentración de lactosuero aumentó la sinéresis y la viscosidad aparente pero disminuyó los sólidos solubles e índice de consistencia. Los cambios en las propiedades se relacionan con el aporte de grasa que realiza el tipo de leche y la contribución de calcio y fosfato que efectúa la adición de lactosuero, afectando tanto la interacción entre las micelas de caseína como la capacidad de retención de agua, que resulta en cambios en la composición y fluidez de la bebida

Bevacizumab plus preoperative chemotherapy in operable HER2 negative breast cancer: biomarkers and pathologic response

Purpose: The primary aim of this trial was to assess the rate of pathologic complete responses (pCR) of doxorubicin/cyclophosphamide (AC) followed by bevacizumab/docetaxel (BT), as neoadjuvant therapy for breast cancer (BC). Furthermore, the association between biomarkers and the pCR was explored. Methods: Patients with HER-negative operable stage II–III BC ≥2 cm were enrolled. Four cycles of AC (A 60 mg/m2 and C 600 mg/m2, every 3 weeks) followed by 4 cycles of BT (B 15 mg/kg and T 75 mg/m2, every 3 weeks), were planned. A core-biopsy was performed for biological markers assessment. Results: Seventy-two women were included. Forty-three (63 %) patients were hormone receptor-positive. Sixty-four (89 %) completed the planned treatment, and 66 evaluable patients underwent surgery (92 %): a pCR was achieved in 16 of them (24, 95 % CI 15–36 %). pCR was significantly higher in tumors hormone receptor-negative, and in those with Angiotensin II type 1 receptor (AGTR1) protein overexpression. The overall clinical response rate was 86 % (95 % CI 76–93 %), including 42 complete responses. No unexpected toxicities or treatment-related deaths were observed. Conclusion: This regimen showed a remarkable clinical and pathological activity: the suggested relation between pCR and AGTR1 overexpression should be confirmed in larger trials.Financial support for this research was provided by Roche Farma, S.A

Autoeficacia y actividad física en niños mexicanos con obesidad y sobrepeso

This is an exploratory, descriptive, research, designed as a field test before and after intervention in non-coupled groups, to work with over weight and obese children and their families (intervention group); versus working without the individual's family members, to assess the degree of self-efficacy for the physical activity Program. Therewere significative differences of self efficacy changes among two groups before and after intervention. Some difficulties related to methodology and instruments were found and practical difficulties were reported such a previous studies with similar interventions studies. Conclusions: Promoting physical requires considering to include in the future another intraindividual characteristics of the children and families such as self-steem, body image and social support environmental.El estudio es una investigación de corte exploratorio, descriptivo como experimento de campo pre y post intervención en grupos pareados para trabajar con niños que tienen obesidad y sobrepeso y sus familias (el grupo de intervención) versus la ausencia de sus familias (grupo control), para evaluar los niveles de autoeficacia en un programa universitario de actividad física. Se encontraron diferencias significativas entre ambos grupos en la pre y la post intervención. Los escasos trabajos de intervención encontrados similares a este estudio en niños con obesidad y sus familias permite comprender las dificultades prácticas reportadas en este y otros estudios tienen que ver con los instrumentos aplicados y la metodología empleada y nos llevan a la conclusión de considerar en futuros estudios variables como autoestima, auto imagen y apoyo social de los niños con obesidad y sus familias

Importancia del roedor Mus musculus en enfermedades infecciosas relevantes en salud pública

El Mus musculus, es una especie de roedor miomorfo de la familia Muridae, comúnmente utilizado en experimentos de laboratorio, subdividiéndose en 4 subespecies; Mus musculus domesticus, Mus musculus musculus, Mus musculus castaneus y Mus musculus bactrianus (1). Es un múrido de tamaño pequeño y aspecto grácil, su peso aproximado es de 12,5 a 29 gr, su cola está recubierta de escamas presentando escaso pelo fino, su hocico es ligeramente puntiagudo, sus ojos son normalmente negros y pequeños, orejas redondeadas, presenta un pelaje de color gris en su etapa de juventud y en etapa adulta su coloración puede variar de clara a oscura (2), posee un numero estándar de cromosomas de 40 n con 19 pares de cromosomas autosómicos

Rate and duration of hospitalisation for acute pulmonary embolism in the real-world clinical practice of different countries : Analysis from the RIETE registry

publishersversionPeer reviewe

Global overview of the management of acute cholecystitis during the COVID-19 pandemic (CHOLECOVID study)

Background: This study provides a global overview of the management of patients with acute cholecystitis during the initial phase of the COVID-19 pandemic. Methods: CHOLECOVID is an international, multicentre, observational comparative study of patients admitted to hospital with acute cholecystitis during the COVID-19 pandemic. Data on management were collected for a 2-month study interval coincident with the WHO declaration of the SARS-CoV-2 pandemic and compared with an equivalent pre-pandemic time interval. Mediation analysis examined the influence of SARS-COV-2 infection on 30-day mortality. Results: This study collected data on 9783 patients with acute cholecystitis admitted to 247 hospitals across the world. The pandemic was associated with reduced availability of surgical workforce and operating facilities globally, a significant shift to worse severity of disease, and increased use of conservative management. There was a reduction (both absolute and proportionate) in the number of patients undergoing cholecystectomy from 3095 patients (56.2 per cent) pre-pandemic to 1998 patients (46.2 per cent) during the pandemic but there was no difference in 30-day all-cause mortality after cholecystectomy comparing the pre-pandemic interval with the pandemic (13 patients (0.4 per cent) pre-pandemic to 13 patients (0.6 per cent) pandemic; P = 0.355). In mediation analysis, an admission with acute cholecystitis during the pandemic was associated with a non-significant increased risk of death (OR 1.29, 95 per cent c.i. 0.93 to 1.79, P = 0.121). Conclusion: CHOLECOVID provides a unique overview of the treatment of patients with cholecystitis across the globe during the first months of the SARS-CoV-2 pandemic. The study highlights the need for system resilience in retention of elective surgical activity. Cholecystectomy was associated with a low risk of mortality and deferral of treatment results in an increase in avoidable morbidity that represents the non-COVID cost of this pandemic

Mortality from gastrointestinal congenital anomalies at 264 hospitals in 74 low-income, middle-income, and high-income countries: a multicentre, international, prospective cohort study

Background: Congenital anomalies are the fifth leading cause of mortality in children younger than 5 years globally. Many gastrointestinal congenital anomalies are fatal without timely access to neonatal surgical care, but few studies have been done on these conditions in low-income and middle-income countries (LMICs). We compared outcomes of the seven most common gastrointestinal congenital anomalies in low-income, middle-income, and high-income countries globally, and identified factors associated with mortality. // Methods: We did a multicentre, international prospective cohort study of patients younger than 16 years, presenting to hospital for the first time with oesophageal atresia, congenital diaphragmatic hernia, intestinal atresia, gastroschisis, exomphalos, anorectal malformation, and Hirschsprung's disease. Recruitment was of consecutive patients for a minimum of 1 month between October, 2018, and April, 2019. We collected data on patient demographics, clinical status, interventions, and outcomes using the REDCap platform. Patients were followed up for 30 days after primary intervention, or 30 days after admission if they did not receive an intervention. The primary outcome was all-cause, in-hospital mortality for all conditions combined and each condition individually, stratified by country income status. We did a complete case analysis. // Findings: We included 3849 patients with 3975 study conditions (560 with oesophageal atresia, 448 with congenital diaphragmatic hernia, 681 with intestinal atresia, 453 with gastroschisis, 325 with exomphalos, 991 with anorectal malformation, and 517 with Hirschsprung's disease) from 264 hospitals (89 in high-income countries, 166 in middle-income countries, and nine in low-income countries) in 74 countries. Of the 3849 patients, 2231 (58·0%) were male. Median gestational age at birth was 38 weeks (IQR 36–39) and median bodyweight at presentation was 2·8 kg (2·3–3·3). Mortality among all patients was 37 (39·8%) of 93 in low-income countries, 583 (20·4%) of 2860 in middle-income countries, and 50 (5·6%) of 896 in high-income countries (p<0·0001 between all country income groups). Gastroschisis had the greatest difference in mortality between country income strata (nine [90·0%] of ten in low-income countries, 97 [31·9%] of 304 in middle-income countries, and two [1·4%] of 139 in high-income countries; p≤0·0001 between all country income groups). Factors significantly associated with higher mortality for all patients combined included country income status (low-income vs high-income countries, risk ratio 2·78 [95% CI 1·88–4·11], p<0·0001; middle-income vs high-income countries, 2·11 [1·59–2·79], p<0·0001), sepsis at presentation (1·20 [1·04–1·40], p=0·016), higher American Society of Anesthesiologists (ASA) score at primary intervention (ASA 4–5 vs ASA 1–2, 1·82 [1·40–2·35], p<0·0001; ASA 3 vs ASA 1–2, 1·58, [1·30–1·92], p<0·0001]), surgical safety checklist not used (1·39 [1·02–1·90], p=0·035), and ventilation or parenteral nutrition unavailable when needed (ventilation 1·96, [1·41–2·71], p=0·0001; parenteral nutrition 1·35, [1·05–1·74], p=0·018). Administration of parenteral nutrition (0·61, [0·47–0·79], p=0·0002) and use of a peripherally inserted central catheter (0·65 [0·50–0·86], p=0·0024) or percutaneous central line (0·69 [0·48–1·00], p=0·049) were associated with lower mortality. // Interpretation: Unacceptable differences in mortality exist for gastrointestinal congenital anomalies between low-income, middle-income, and high-income countries. Improving access to quality neonatal surgical care in LMICs will be vital to achieve Sustainable Development Goal 3.2 of ending preventable deaths in neonates and children younger than 5 years by 2030

Informe: Derecho del trabajo y de la seguridad social en España en 2013. Algunos puntos críticos

Este documento intenta reflejar algunos de los principales cambios y novedades del ordenamiento laboral español en 2013, levantando acta de cómo la mutabilidad de nuestro Derecho del Trabajo es imparable. Este informe, consciente de ello, ofrece una selección de elementos esenciales, a juicio de sus autores, especialistas en cada una de las materias, encuadrados en la Sección Juvenil de la Asociación Española de Derecho del Trabajo y de la Seguridad Social. En él, conforme a la organización de dicha Sección en grupos de trabajo, se abordan las novedades más relevantes en materia de derechos fundamentales inespecíficos, contratación laboral, vicisitudes del contrato de trabajo, Derecho colectivo, conciliación y corresponsabilidad, protección social y prevención de riesgos laborales. This paper tries to show some of the many changes and novelties in Spanish Labour Law during 2013, drawing up a record of the unstoppable character of our Labour legal system. This report offers a selection of essential elements, according to its authors, all of them specialists in each one of the subjects, being part of the Young Scholars’ Section of the Spanish Association for Labour and Social Security Law. According to the organization of the said Section in working groups, we can find novelties concerning unspecific fundamental rights, work contracts, the life of the work contract and collective Labour Law, reconciliation and co responsibility, social protection and occupational risk prevention